23andMe cuts 40% of its workforce and discontinues therapeutics division
Back in September, all of 23andMe’s independent directors also resigned from its board — in a rare move that followed drawn-out negotiations with Wojcicki, who has been trying to take the company private. The seven resigning directors said they had yet ...
Back in September, all of 23andMe's independent directors also resigned from its board — a rare move that followed ...
Embattled genetic testing provider 23andMe said on Tuesday that revenue declined from a year earlier, a day after the company ...
In another blow to the company, seven of 23andMe’s eight-strong board resigned in September. The firm's independent ...
Business Insider on MSN13d
23andMe appoints new board members as it works to stem the company's slideMe said it appointed three new independent directors to its board on Monday. All seven of 23andMe's previous directors ...
Back in September, all of 23andMe’s independent directors also resigned from its board — in a rare move that followed ...
On Tuesday, Wojcicki announced the new additions to 23andMe’s board: Andre Fernandez, a former CFO at WeWork, Inc., and NCR ...
In September, independent directors of the Board of 23andMe sent a letter to Anne Wojcicki, Chief Executive Officer, Co ...
Shares were hovering below $1 until 23andMe announced a 1-for-20 reverse stock split in October. In September, all seven of ...
Holding “announced a business restructuring to streamline operations and reduce costs. In addition, 23andMe is discontinuing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback